Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Cyclo Therapeutics stock | 0.12

Own Cyclo Therapeutics stock in just a few minutes.

Updated . What changed?

Fact checked

Cyclo Therapeutics stock is currently available to purchase as an over-the-counter (OTC) stock on the OTCQB. But many popular brokerages don't offer access to OTC stocks.

Cyclo has recently filed with the SEC to list stock on the Nasdaq Capital Market. This will make it possible to buy its stock from any major stock broker.

How to buy shares in Cyclo Therapeutics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Cyclo Therapeutics. Find the stock by name or ticker symbol: CTDH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cyclo Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$0.12, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Cyclo Therapeutics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Cyclo Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Cyclo Therapeutics's share price?

Since the stock market crash in March caused by coronavirus, Cyclo Therapeutics's share price has had significant negative movement.

Its last market close was USD$0.12, which is 40.00% down on its pre-crash value of USD$0.2 and 50.00% up on the lowest point reached during the March crash when the shares fell as low as USD$0.08.

If you had bought USD$1,000 worth of Cyclo Therapeutics shares at the start of February 2020, those shares would have been worth USD$818.18 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$545.45.

Cyclo Therapeutics share price

Use our graph to track the performance of CTDH stocks over time.

Cyclo Therapeutics shares at a glance

Information last updated 2020-10-16.
Latest market closeUSD$0.12
52-week rangeUSD$0.08 - USD$0.3499
50-day moving average USD$0.1444
200-day moving average USD$0.1555
Wall St. target priceUSD$1.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.059

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
A free way to invest in stocks, ETFs and crypto.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cyclo Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cyclo Therapeutics price performance over time

Historical closes compared with the close of $0.12 from 2020-10-19

1 week (2020-10-16) 0.12
1 month (2020-09-25) -7.69%
3 months (2020-07-24) -14.29%
6 months (2020-04-24) -29.41%
1 year (2019-10-25) -36.84%
2 years (2018-10-24) -78.38%
3 years (2017-10-24) -70.00%
5 years (2015-10-23) -79.66%

Cyclo Therapeutics financials

Revenue TTM USD$1 million
Gross profit TTM USD$769,638
Return on assets TTM -115.58%
Return on equity TTM -622.39%
Profit margin 0%
Book value $0.029
Market capitalisation USD$19.7 million

TTM: trailing 12 months

Cyclo Therapeutics share dividends

We're not expecting Cyclo Therapeutics to pay a dividend over the next 12 months.

Have Cyclo Therapeutics's shares ever split?

Cyclo Therapeutics's shares were split on a 2:1 basis on 22 May 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cyclo Therapeutics shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cyclo Therapeutics shares which in turn could have impacted Cyclo Therapeutics's share price.

Cyclo Therapeutics share price volatility

Over the last 12 months, Cyclo Therapeutics's shares have ranged in value from as little as $0.08 up to $0.3499. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Cyclo Therapeutics's is -0.4986. This would suggest that Cyclo Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Cyclo Therapeutics has bucked the trend.

To put Cyclo Therapeutics's beta into context you can compare it against those of similar companies.

Cyclo Therapeutics overview

Cyclo Therapeutics, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. It has a collaboration with the Chattanooga Center for Neurologic Research. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in October 2019. Cyclo Therapeutics, Inc. was founded in 1990 and is based in Gainesville, Florida.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site